XOMA Co. (NASDAQ:XOMAP – Get Free Report) saw a large growth in short interest in the month of June. As of June 15th, there was short interest totaling 556 shares, a growth of 561.9% from the May 31st total of 84 shares. Based on an average daily volume of 1,420 shares, the short-interest ratio is presently 0.4 days.
XOMA Stock Performance
XOMAP opened at $25.47 on Friday. The firm has a 50-day moving average of $25.52 and a 200 day moving average of $26.04. XOMA has a fifty-two week low of $25.14 and a fifty-two week high of $30.00.
XOMA Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 14th. Shareholders of record on Thursday, July 2nd will be paid a $0.5391 dividend. This represents a $2.16 dividend on an annualized basis and a yield of 8.5%. The ex-dividend date is Thursday, July 2nd.
XOMA Company Profile
XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.
Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.
Featured Articles
- Five stocks we like better than XOMA
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
